Canadian magic mushrooms and truffles producer Red Light Holland Corp. TRUFF’s wholly-owned subsidiary, health tech firm Radix Motion Inc., has received an International Preliminary Report on Patentability for its patent application on 3D movement data usage in psychedelic therapy.
"Red Light Holland continues to work with a stellar team to protect our unique intellectual property aimed at increasing the benefits and responsible access to natural psilocybin," said Red Light’s CEO and director Todd Shapiro.
The Patent
With the patent first filed in July 2020, a USPTO examiner found that all seven claims comprised in the application are novel, and have both an inventive step and “industrial applicability” (utility.)
See also: Free Ketamine Therapy? Laid-Off Tech Workers Can Request Month Of 'Freedom' Program
The examiner found that the claims were not previously made, which renders them allowable and eligible for fast-track examination under the Patent Prosecution Highway in the US, Canada and other participating patent offices.
Data As A Key
Red Light CIO and Radix CEO Sarah Hashkes explained that the company aims to combine psychedelic usage data with technology that understands human bodies and how they move, in order to customize treatments and interventions to increase potential benefits while also utilizing “objective data for research and legalization efforts.”
Red Light’s patent advisor Graham Pechenik shared his thrill to participate in both companies' “unique and ethical approach to patents that takes into account user privacy and seeks to protect innovative technology.”
See also: Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project
Pechenik believes the latest reviews by the USPTO examiner constitute “a great step” towards potentially being granted a patent, as “the opinion indicates that all of the method claims relating to psychedelic therapy are allowable as written, and it suggests how the broader claims can be amended to cover the inventors' contributions in ways that are allowable too.”
Photo courtesy of Susie Hedberg and C4289N on Shutterstock.
Nuestro contenido en Español:
-
Acciones de HEXO en Nasdaq: Toda la Información y Noticias
-
Acciones de Marihuana: Cómo Invertir
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.